PDCD1 and neoplasm: Combined with anti-PD-1, chitin further and significantly reduced primary tumor growth compared to untreated, anti-PD-1- and chitin-treated tumor-bearing mice in both the 4T1- and 66cl4-based model (Fig. 1B–G).